This suggests that these nerve cells control the beneficial effects of semaglutide. We have therefore identified a specific group of nerve cells that is necessary for the effects that semaglutide has on weight and appetite, but which does not appear to contribute to any significant extent to side effects such as nausea.
"These staggering numbers mean that we are likely to see large increases in spending on semaglutide and related medications in years to come," said Dhruv S. Kazi, emphasizing the financial implications as more adults become eligible for this treatment.